AMTI
NASDAQApplied Molecular Transport Inc.
Latest news
25 items- 13D/GSEC Form SC 13G/A filed by Applied Molecular Transport Inc. (Amendment)SC 13G/A - Applied Molecular Transport Inc. (0001801777) (Subject)
- SECSEC Form 15-12G filed by Applied Molecular Transport Inc.15-12G - Applied Molecular Transport Inc. (0001801777) (Filer)
- 13D/GSEC Form SC 13D/A filed by Applied Molecular Transport Inc. (Amendment)SC 13D/A - Applied Molecular Transport Inc. (0001801777) (Subject)
- SECSEC Form EFFECT filed by Applied Molecular Transport Inc.EFFECT - Applied Molecular Transport Inc. (0001801777) (Filer)
- SECSEC Form POSASR filed by Applied Molecular Transport Inc.POSASR - Applied Molecular Transport Inc. (0001801777) (Filer)
- SECSEC Form POS AM filed by Applied Molecular Transport Inc.POS AM - Applied Molecular Transport Inc. (0001801777) (Filer)
- SECSEC Form S-8 POS filed by Applied Molecular Transport Inc.S-8 POS - Applied Molecular Transport Inc. (0001801777) (Filer)
- SECSEC Form S-8 POS filed by Applied Molecular Transport Inc.S-8 POS - Applied Molecular Transport Inc. (0001801777) (Filer)
- SECSEC Form S-8 POS filed by Applied Molecular Transport Inc.S-8 POS - Applied Molecular Transport Inc. (0001801777) (Filer)
- INSIDEREpiq Capital Group, Llc disposed of 8,337,518 shares (SEC Form 4)4 - Applied Molecular Transport Inc. (0001801777) (Issuer)
- INSIDERVandevender Aaron returned 212,659 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Applied Molecular Transport Inc. (0001801777) (Issuer)
- INSIDERSEC Form 4 filed by Smither John W4 - Applied Molecular Transport Inc. (0001801777) (Issuer)
- INSIDERSEC Form 4 filed by Schachner Holly Caren4 - Applied Molecular Transport Inc. (0001801777) (Issuer)
- INSIDERMahmood Tahir Ph.D. returned 4,084,738 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Applied Molecular Transport Inc. (0001801777) (Issuer)
- INSIDERHants Brandon returned 301,225 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Applied Molecular Transport Inc. (0001801777) (Issuer)
- INSIDERCross Shawn returned 545,499 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Applied Molecular Transport Inc. (0001801777) (Issuer)
- INSIDERSEC Form 4 filed by Banard Charlene A.4 - Applied Molecular Transport Inc. (0001801777) (Issuer)
- INSIDERSEC Form 4 filed by Hants Brandon4 - Applied Molecular Transport Inc. (0001801777) (Issuer)
- SECSEC Form 25-NSE filed by Applied Molecular Transport Inc.25-NSE - Applied Molecular Transport Inc. (0001801777) (Subject)
- PRCyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.Combined company operating as Cyclo Therapeutics with primary focus on advancing Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 (NPC1) Cash runway extended into 2H 2024 with approximately $11.0 million cash on hand to fund operations Cyclo Therapeutics, Inc. (NASDAQ:CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company focused on developing transformative therapies for rare and neurological diseases with limited treatment options, and Applied Molecular Transport Inc. (NASDAQ:AMTI) ("AMT"), a biopharmaceutical company, announced today the closing of its previously announced transaction pursuant to which AMT will merge with Cyclo Therape
- SECApplied Molecular Transport Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Applied Molecular Transport Inc. (0001801777) (Filer)
- SECApplied Molecular Transport Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Applied Molecular Transport Inc. (0001801777) (Filer)
- SECSEC Form DEFA14A filed by Applied Molecular Transport Inc.DEFA14A - Applied Molecular Transport Inc. (0001801777) (Filer)
- SECApplied Molecular Transport Inc. filed SEC Form 8-K: Other Events8-K - Applied Molecular Transport Inc. (0001801777) (Filer)
- INSIDERMahmood Tahir Ph.D. sold $46,785 worth of shares (286,320 units at $0.16), decreasing direct ownership by 37% to 484,738 units (SEC Form 4)4 - Applied Molecular Transport Inc. (0001801777) (Issuer)
AMTI FAQ
6 questionsWhat does Applied Molecular Transport Inc. do?
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammatory indications. It is also involved in developing AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase Ia clinical trial for diseases related to...Where does AMTI stock trade?
Applied Molecular Transport Inc. (AMTI) is listed on NASDAQ.What sector and industry is AMTI in?
Applied Molecular Transport Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Applied Molecular Transport Inc. go public?
Applied Molecular Transport Inc. (AMTI) completed its IPO in 2020.What companies are similar to AMTI?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), AZN (AstraZeneca PLC), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare AMTI side-by-side with any of them on Quantisnow.How can I track AMTI on Quantisnow?
Quantisnow aggregates Applied Molecular Transport Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AMTI to receive live email and push alerts on every new disclosure.